Zobrazeno 1 - 10
of 552
pro vyhledávání: '"Peter Palese"'
Autor:
Stefan Slamanig, Irene González-Domínguez, Lauren A. Chang, Nicholas Lemus, Tsoi Ying Lai, Jose Luis Martínez, Gagandeep Singh, Victoria Dolange, Adam Abdeljawad, Shreyas Kowdle, Moataz Noureddine, Prajakta Warang, Benhur Lee, Adolfo García-Sastre, Florian Krammer, Michael Schotsaert, Peter Palese, Weina Sun
Publikováno v:
EBioMedicine, Vol 105, Iss , Pp 105185- (2024)
Summary: Background: In order to prevent the emergence and spread of future variants of concern of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), developing vaccines capable of stopping transmission is crucial. The SARS-CoV-2 vaccine N
Externí odkaz:
https://doaj.org/article/18bda2ebe71446cb81d8e9be9b791fab
Autor:
Carly M. Bliss, Raffael Nachbagauer, Chiara Mariottini, Frans Cuevas, Jodi Feser, Abdi Naficy, David I. Bernstein, Jeffrey Guptill, Emmanuel B. Walter, Francesco Berlanda-Scorza, Bruce L. Innis, Adolfo García-Sastre, Peter Palese, Florian Krammer, Lynda Coughlan
Publikováno v:
EBioMedicine, Vol 104, Iss , Pp 105153- (2024)
Summary: Background: The development of a universal influenza virus vaccine, to protect against both seasonal and pandemic influenza A viruses, is a long-standing public health goal. The conserved stalk domain of haemagglutinin (HA) is a promising va
Externí odkaz:
https://doaj.org/article/c9ca6df22ec740d499055ef8fed469f9
Autor:
Alejandro Torres-Flores, Luis Alberto Ontiveros-Padilla, Ruth Lizzeth Madera-Sandoval, Araceli Tepale-Segura, Julián Gajón-Martínez, Tania Rivera-Hernández, Eduardo Antonio Ferat-Osorio, Arturo Cérbulo-Vázquez, Lourdes Andrea Arriaga-Pizano, Laura Bonifaz, Georgina Paz-De la Rosa, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, David Sarfati-Mizrahi, Weina Sun, Héctor Elías Chagoya-Cortés, Peter Palese, Florian Krammer, Adolfo García-Sastre, Bernardo Lozano-Dubernard, Constantino López-Macías
Publikováno v:
Frontiers in Immunology, Vol 15 (2024)
IntroductionSeveral effective vaccines for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed and implemented in the population. However, the current production capacity falls short of meeting global demand. Therefore, i
Externí odkaz:
https://doaj.org/article/f59adc9f44cc4bf6920104dbbb786afe
Autor:
Kristien Van Reeth, Anna Parys, José Carlos Mancera Gracia, Ivan Trus, Koen Chiers, Philip Meade, Sean Liu, Peter Palese, Florian Krammer, Elien Vandoorn
Publikováno v:
Nature Communications, Vol 14, Iss 1, Pp 1-18 (2023)
Abstract Vaccines that protect against any H1N1 influenza A virus strain would be advantageous for use in pigs and humans. Here, we try to induce a pan-H1N1 antibody response in pigs by sequential vaccination with antigenically divergent H1N1 strains
Externí odkaz:
https://doaj.org/article/3f2b82ff53d24547bc30298e3d7a0e1f
Interim safety and immunogenicity results from an NDV-based COVID-19 vaccine phase I trial in Mexico
Autor:
Samuel Ponce-de-León, Martha Torres, Luis Enrique Soto-Ramírez, Juan José Calva, Patricio Santillán-Doherty, Dora Eugenia Carranza-Salazar, Juan Manuel Carreño, Claudia Carranza, Esmeralda Juárez, Laura E. Carreto-Binaghi, Luis Ramírez-Martínez, Georgina Paz De la Rosa, Rosalía Vigueras-Moreno, Alejandro Ortiz-Stern, Yolanda López-Vidal, Alejandro E. Macías, Jesús Torres-Flores, Oscar Rojas-Martínez, Alejandro Suárez-Martínez, Gustavo Peralta-Sánchez, Hisaaki Kawabata, Irene González-Domínguez, José Luis Martínez-Guevara, Weina Sun, David Sarfati-Mizrahi, Ernesto Soto-Priante, Héctor Elías Chagoya-Cortés, Constantino López-Macías, Felipa Castro-Peralta, Peter Palese, Adolfo García-Sastre, Florian Krammer, Bernardo Lozano-Dubernard
Publikováno v:
npj Vaccines, Vol 8, Iss 1, Pp 1-14 (2023)
Abstract There is still a need for safe, efficient, and low-cost coronavirus disease 2019 (COVID-19) vaccines that can stop transmission of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Here we evaluated a vaccine candidate based on a
Externí odkaz:
https://doaj.org/article/d2ac0c69327549fb9217708e2039498c
Autor:
Teresa Aydillo, Ana S. Gonzalez-Reiche, Daniel Stadlbauer, Mary Anne Amper, Venugopalan D. Nair, Chiara Mariottini, Stuart C. Sealfon, Harm van Bakel, Peter Palese, Florian Krammer, Adolfo García-Sastre
Publikováno v:
npj Vaccines, Vol 7, Iss 1, Pp 1-14 (2022)
Abstract A phase 1 clinical trial to test the immunogenicity of a chimeric group 1 HA (cHA) universal influenza virus vaccine targeting the conserved stalk domain of the hemagglutinin of influenza viruses was carried out. Vaccination with adjuvanted-
Externí odkaz:
https://doaj.org/article/8b794dc1a4914540906c55991b10614c
Autor:
Eduard Puente-Massaguer, Annika Beyer, Madhumathi Loganathan, Iden Sapse, Juan Manuel Carreño, Goran Bajic, Weina Sun, Peter Palese, Florian Krammer
Publikováno v:
Frontiers in Bioengineering and Biotechnology, Vol 11 (2023)
Seasonal influenza viruses account for 1 billion infections worldwide every year, including 3–5 million cases of severe illness and up to 650,000 deaths. The effectiveness of current influenza virus vaccines is variable and relies on the immunodomi
Externí odkaz:
https://doaj.org/article/79d4755682f742bc909d6415d153112d
Autor:
Laura Sánchez-de Prada, Iván Sanz-Muñoz, Weina Sun, Peter Palese, Raúl Ortiz de Lejarazu, José María Eiros, Adolfo García-Sastre, Teresa Aydillo
Publikováno v:
Frontiers in Immunology, Vol 14 (2023)
ObjectiveAntibodies elicited by seasonal influenza vaccines mainly target the head of hemagglutinin (HA). However, antibodies against the stalk domain are cross-reactive and have been proven to play a role in reducing influenza disease severity. We i
Externí odkaz:
https://doaj.org/article/0f9000222055435b9a351171fdc3f802
Autor:
Raveen Rathnasinghe, Mirella Salvatore, Hongyong Zheng, Sonia Jangra, Thomas Kehrer, Ignacio Mena, Michael Schotsaert, Thomas Muster, Peter Palese, Adolfo García-Sastre
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-12 (2021)
Abstract The influenza A non-structural protein 1 (NS1) is known for its ability to hinder the synthesis of type I interferon (IFN) during viral infection. Influenza viruses lacking NS1 (ΔNS1) are under clinical development as live attenuated human
Externí odkaz:
https://doaj.org/article/40093ba6def04ffd8471e4167f233f58
Autor:
Weina Sun, Yonghong Liu, Fatima Amanat, Irene González-Domínguez, Stephen McCroskery, Stefan Slamanig, Lynda Coughlan, Victoria Rosado, Nicholas Lemus, Sonia Jangra, Raveen Rathnasinghe, Michael Schotsaert, Jose L. Martinez, Kaori Sano, Ignacio Mena, Bruce L. Innis, Ponthip Wirachwong, Duong Huu Thai, Ricardo Das Neves Oliveira, Rami Scharf, Richard Hjorth, Rama Raghunandan, Florian Krammer, Adolfo García-Sastre, Peter Palese
Publikováno v:
Nature Communications, Vol 12, Iss 1, Pp 1-14 (2021)
Here the authors show that a Newcastle disease virus based COVID-19 vaccine expressing a stabilized spike protein induces protective immunity in small animal models and reduces replication of variants of concerns. This vaccine candidate can be produc
Externí odkaz:
https://doaj.org/article/f1e4a5e7803b4a489c63923de224b4aa